Bennett, S, 2004 Quality rating: Fair


Study design: RCT NR NR

  • Run-in : 28 days
  • Setting: Multicenter
  • Wash out : NR
  • Country: UK

Sample: Number Screened/Eligible/Enrolled Number Withdrawn/Lost to follow-up/Analyzed

58/NR/40 NR/NR/18

Inclusion criteria:

Patients with consistent IGT, BMI 22–39 kg/m

Exclusion criteria:

Significant anemia, renal or hepatic disease, congestive heart failure, BP >180 mm Hg or BP >110 mm Hg



  • Mean age: 59.7 years
  • Ethnicity: White 100%
  • Gender: 90% Female
  • Type 2 diabetes duration (SD): NR

Intervention: monotherapy

Duration: 12 week


Laboratory measures:


Physiologic outcomes:


Health outcomes:


P value NR if not specified.

From: Evidence Tables

Cover of Drug Class Review: Thiazolidinediones
Drug Class Review: Thiazolidinediones: Final Report Update 1 [Internet].
Norris SL, Carson S, Thakurta S, et al.
Portland (OR): Oregon Health & Science University; 2008 Aug.
Copyright © 2008, Oregon Health & Science University, Portland, Oregon.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.